SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEART

Autor: Rosén, Hans Christian, Mohammad, Moman A., Jernberg, Tomas, James, Stefan, Oldgren, Jonas, Erlinge, David
Zdroj: In The Lancet Regional Health - Europe October 2024 45
Databáze: ScienceDirect